Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Vallés, Martí"'
Autor:
Andrea Vallés‐Martí, Richard R. deGoeij‐de Haas, Alex A. Henneman, Sander R. Piersma, Thang V. Pham, Jaco C. Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R. Jiménez, Maarten F. Bijlsma
Publikováno v:
Molecular Oncology, Vol 18, Iss 8, Pp 2020-2041 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited number of known driver mutations but considerable cancer cell heterogeneity. Phosphoproteomics provides a direct read‐out of aberrant signaling and the resultant clinic
Externí odkaz:
https://doaj.org/article/e8ff82023c7546bf9b7c1d4e26f666f5
Autor:
Vallés-Martí, Andrea, Mantini, Giulia, Manoukian, Paul, Waasdorp, Cynthia, Sarasqueta, Arantza Fariña, de Goeij-de Haas, Richard R., Henneman, Alex A., Piersma, Sander R., Pham, Thang V., Knol, Jaco C., Giovannetti, Elisa, Bijlsma, Maarten F., Jiménez, Connie R.
Publikováno v:
In Cell Reports 27 June 2023 42(6)
Autor:
Esther E. E. Drees, Julia Driessen, Gerben J. C. Zwezerijnen, Sandra A. W. M. Verkuijlen, Jakoba J. Eertink, Monique A. J. vanEijndhoven, Nils J. Groenewegen, Andrea Vallés‐Martí, Daphne deJong, Ronald Boellaard, Henrica C. W. deVet, Dirk M. Pegtel, Josée M. Zijlstra
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 908-912 (2022)
Abstract Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers relate to quantitative 18F‐FDG‐PET features. We correlated extracellular vesic
Externí odkaz:
https://doaj.org/article/8a2200b23a984d21aa0f98dc54ac8e5b
Autor:
Andrea Vallés-Martí, Giulia Mantini, Paul Manoukian, Cynthia Waasdorp, Arantza Fariña Sarasqueta, Richard R. de Goeij-de Haas, Alex A. Henneman, Sander R. Piersma, Thang V. Pham, Jaco C. Knol, Elisa Giovannetti, Maarten F. Bijlsma, Connie R. Jiménez
Publikováno v:
Cell Reports, Vol 42, Iss 6, Pp 112581- (2023)
Summary: Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited set of known driver mutations but considerable cancer cell heterogeneity. Phosphoproteomics provides a readout of aberrant signaling and has the potential to ide
Externí odkaz:
https://doaj.org/article/a376cfbd793a4fad84b5fc0527c68328
Publikováno v:
In Journal of Hydrology May 2022 608
Autor:
Vallés‐Martí, Andrea, de Goeij‐de Haas, Richard R., Henneman, Alex A., Piersma, Sander R., Pham, Thang V., Knol, Jaco C., Verheij, Joanne, Dijk, Frederike, Halfwerk, Hans, Giovannetti, Elisa, Jiménez, Connie R., Bijlsma, Maarten F.
Publikováno v:
Molecular Oncology; Aug2024, Vol. 18 Issue 8, p2020-2041, 22p
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-44 (2021)
Abstract Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early phase clinical trials have confirmed safety and indicated efficacy of IVC
Externí odkaz:
https://doaj.org/article/382bf00c77f64c89bc652c2e4ca8c0ae
Autor:
Esther E. E. Drees, Margaretha G. M. Roemer, Nils J. Groenewegen, Jennifer Perez‐Boza, Monique A. J. vanEijndhoven, Leah I. Prins, Sandra A. W. M. Verkuijlen, Xuan‐Mai Tran, Julia Driessen, G. J. C. Zwezerijnen, Phylicia Stathi, Kevin Mol, Joey J. J. P. Karregat, Aikaterini Kalantidou, Andrea Vallés‐Martí, T. J. Molenaar, Ernesto Aparicio‐Puerta, Erik vanDijk, Bauke Ylstra, Catharina G. M. Groothuis‐Oudshoorn, Michael Hackenberg, Daphne deJong, Josée M. Zijlstra, D. Michiel Pegtel
Publikováno v:
Journal of Extracellular Vesicles, Vol 10, Iss 9, Pp n/a-n/a (2021)
Abstract Minimally‐invasive tools to assess tumour presence and burden may improve clinical management. FDG‐PET (metabolic) imaging is the current gold standard for interim response assessment in patients with classical Hodgkin Lymphoma (cHL), bu
Externí odkaz:
https://doaj.org/article/dd7ff80e47294223ac9069d292d8a4bd
Autor:
Böttger, Franziska1 (AUTHOR), Vallés-Martí, Andrea1 (AUTHOR), Cahn, Loraine1 (AUTHOR), Jimenez, Connie R.1 (AUTHOR) c.jimenez@amsterdamumc.nl
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 10/30/2021, Vol. 40 Issue 1, p1-44. 44p.
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-44 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Böttger, F, Vallés, AV, Cahn, L & Jimenez, C R 2021, ' High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer ', JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol. 40, no. 1, pp. 343 . https://doi.org/10.1186/s13046-021-02134-y
Journal of Experimental & Clinical Cancer Research : CR
Böttger, F, Vallés, AV, Cahn, L & Jimenez, C R 2021, ' High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer ', JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol. 40, no. 1, pp. 343 . https://doi.org/10.1186/s13046-021-02134-y
Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose IVC). Early phase clinical trials have confirmed safety and indicated efficacy of IVC in eradic